{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T22:03:36Z","timestamp":1791497016190,"version":"4.3.4"},"update-to":[{"DOI":"10.1371\/journal.ppat.1013086","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000}}],"reference-count":73,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100015691","name":"Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01 AI038382"],"award-info":[{"award-number":["R01 AI038382"]}],"id":[{"id":"10.13039\/100015691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R35 CA209979"],"award-info":[{"award-number":["R35 CA209979"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005895","name":"Fred Hutchinson Cancer Research Center","doi-asserted-by":"publisher","award":["PAM IRC"],"award-info":[{"award-number":["PAM IRC"]}],"id":[{"id":"10.13039\/100005895","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R24 GM154185"],"award-info":[{"award-number":["R24 GM154185"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005895","name":"Fred Hutchinson Cancer Research Center","doi-asserted-by":"publisher","award":["P30 CA015704"],"award-info":[{"award-number":["P30 CA015704"]}],"id":[{"id":"10.13039\/100005895","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NIH","award":["1S10OD028581-01"],"award-info":[{"award-number":["1S10OD028581-01"]}]}],"content-domain":{"domain":["www.plospathogens.org"],"crossmark-restriction":false},"short-container-title":["PLoS Pathog"],"abstract":"<jats:p>\n                    Antibodies to human papillomavirus (HPV) primarily recognize surface exposed residues on five loops of the major capsid protein (L1) that vary significantly among HPV types. We determined which loops were required for neutralization for 68 HPV16 specific human monoclonal antibodies (mAbs) cloned from participants who received an HPV vaccine and describe molecular features of those antibodies. Chimeric HPV16 pseudovirus (cpsV), each having one surface loop bearing multiple amino acid substitutions, were used to determine neutralization specificity. The HPV16-FG-loop was the loop most frequently required for neutralization (42 of 68, 61.8%), however, all surface loops were required for neutralization by multiple mAbs: HI (13, 19.1%), DE (15, 22.1%), EF (five, 7.4%), BC (four, 5.9%). Antibodies that required multiple loops were common (17, 25.0%). Three mAbs (4.4%) required sequences on the c-terminus of L1 and for another three mAbs the neutralization specificity could not be determined. Two types of mAbs appeared to be overrepresented: ten mAbs used immunoglobin heavy chain variable region 2\u201370 (IGHV2\u201370) with immunoglobin light chain variable region 1\u201340 (IGLV1\u201340), having characteristic mutations in complementarity determining region two (CDRL2) of the light chain. Cryogenic electron microscopy (Cryo-EM) revealed that two of these antibodies bound five Fabs per capsomer interacting with all five L1-surface loops. The other type of mAbs that appeared to be overrepresented were nine mAbs using IGHV4\u201334, six of which also used D\n                    <jats:sub>H<\/jats:sub>\n                    3-16*02 with conserved CDRH3 sequences. Cryo-EM for one of these mAbs, that required the FG-loop for neutralization, was shown to bind one Fab per capsomer at the apex, interacting with the DE- and FG-loops, with sequences of the Fab CDRH3 inserted between the DE- and FG-loops from two L1 proteins. These two types of mAbs were found in the four participants suggesting that these antibodies shared developmental pathways and bound to similar immunodominant epitopes on the virus.\n                  <\/jats:p>","DOI":"10.1371\/journal.ppat.1013086","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T17:31:58Z","timestamp":1761067918000},"page":"e1013086","update-policy":"https:\/\/doi.org\/10.1371\/journal.ppat.corrections_policy","source":"Crossref","is-referenced-by-count":4,"title":["Human monoclonal antibodies to HPV16 show evidence for common developmental pathways and public epitopes"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6825-1453","authenticated-orcid":true,"given":"Joseph J.","family":"Carter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas K.","family":"Hurlburt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin M.","family":"Scherer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suruchi","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justas V.","family":"Rodarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin A.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Kinzelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Kieltyka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madelyn E.","family":"Cab\u00e3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory C.","family":"Wipf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Pancera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6713-6127","authenticated-orcid":true,"given":"Denise A.","family":"Galloway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,10,21]]},"reference":[{"issue":"4","key":"ppat.1013086.ref001","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1136\/jcp.55.4.244","article-title":"The causal relation between human papillomavirus and cervical cancer","volume":"55","author":"FX Bosch","year":"2002","journal-title":"J Clin Pathol"},{"issue":"4","key":"ppat.1013086.ref002","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/ijc.30716","article-title":"Worldwide burden of cancer attributable to HPV by site, country and HPV type","volume":"141","author":"C de Martel","year":"2017","journal-title":"Int J Cancer"},{"issue":"29","key":"ppat.1013086.ref003","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1200\/JCO.2015.61.6995","article-title":"Epidemiology of Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma","volume":"33","author":"ML Gillison","year":"2015","journal-title":"J Clin Oncol"},{"issue":"1","key":"ppat.1013086.ref004","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/sj.bjc.6600688","article-title":"Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis","volume":"88","author":"GM Clifford","year":"2003","journal-title":"Br J Cancer"},{"issue":"12","key":"ppat.1013086.ref005","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/S1470-2045(20)30524-6","article-title":"Efficacy of the bivalent HPV vaccine against HPV 16\/18-associated precancer: long-term follow-up results from the Costa Rica Vaccine Trial","volume":"21","author":"C Porras","year":"2020","journal-title":"Lancet Oncol"},{"issue":"1","key":"ppat.1013086.ref006","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ygyno.2017.04.004","article-title":"HPV vaccines - A review of the first decade","volume":"146","author":"DM Harper","year":"2017","journal-title":"Gynecol Oncol"},{"key":"ppat.1013086.ref007","volume-title":"Human papillomavirus vaccines: WHO position paper","author":"World Health Organization","year":"2014"},{"key":"ppat.1013086.ref008","article-title":"WHO Approves Another HPV Vaccine for Single-Dose Use","author":"S Anderer","year":"2024","journal-title":"JAMA"},{"key":"ppat.1013086.ref009","doi-asserted-by":"crossref","first-page":"100486","DOI":"10.1016\/j.jvacx.2024.100486","article-title":"Efficacy and immunogenicity of a single dose of human papillomavirus vaccine compared to multidose vaccination regimens or no vaccination: An updated systematic review of evidence from clinical trials","volume":"19","author":"HS Whitworth","year":"2024","journal-title":"Vaccine X"},{"issue":"37","key":"ppat.1013086.ref010","doi-asserted-by":"crossref","first-page":"5413","DOI":"10.1016\/j.vaccine.2022.06.065","article-title":"Human papillomavirus vaccine effectiveness by number of doses: Updated systematic review of data from national immunization programs","volume":"40","author":"LE Markowitz","year":"2022","journal-title":"Vaccine"},{"issue":"3","key":"ppat.1013086.ref011","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S1097-2765(00)80449-9","article-title":"Structure of small virus-like particles assembled from the L1 protein of human papillomavirus 16","volume":"5","author":"XS Chen","year":"2000","journal-title":"Mol Cell"},{"issue":"18","key":"ppat.1013086.ref012","doi-asserted-by":"crossref","first-page":"4754","DOI":"10.1093\/emboj\/cdf494","article-title":"Atomic model of the papillomavirus capsid","volume":"21","author":"Y Modis","year":"2002","journal-title":"EMBO J"},{"issue":"21","key":"ppat.1013086.ref013","doi-asserted-by":"crossref","first-page":"11625","DOI":"10.1128\/JVI.77.21.11625-11632.2003","article-title":"Identification of a human papillomavirus type 16-specific epitope on the C-terminal arm of the major capsid protein L1","volume":"77","author":"JJ Carter","year":"2003","journal-title":"J Virol"},{"issue":"23","key":"ppat.1013086.ref014","doi-asserted-by":"crossref","first-page":"12108","DOI":"10.1128\/JVI.02020-15","article-title":"The U4 Antibody Epitope on Human Papillomavirus 16 Identified by Cryo-electron Microscopy","volume":"89","author":"J Guan","year":"2015","journal-title":"J Virol"},{"issue":"6","key":"ppat.1013086.ref015","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.str.2016.04.008","article-title":"The C-Terminal Arm of the Human Papillomavirus Major Capsid Protein Is Immunogenic and Involved in Virus-Host Interaction","volume":"24","author":"Z Li","year":"2016","journal-title":"Structure"},{"issue":"7","key":"ppat.1013086.ref016","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1002\/pro.156","article-title":"Identification of neutralizing conformational epitopes on the human papillomavirus type 31 major capsid protein and functional implications","volume":"18","author":"MJJ Fleury","year":"2009","journal-title":"Protein Sci"},{"key":"ppat.1013086.ref017","doi-asserted-by":"crossref","first-page":"39730","DOI":"10.1038\/srep39730","article-title":"The DE and FG loops of the HPV major capsid protein contribute to the epitopes of vaccine-induced cross-neutralising antibodies","volume":"6","author":"SL Bissett","year":"2016","journal-title":"Sci Rep"},{"issue":"10","key":"ppat.1013086.ref018","doi-asserted-by":"crossref","first-page":"4664","DOI":"10.1128\/JVI.80.10.4664-4672.2006","article-title":"Identification of human papillomavirus type 16 L1 surface loops required for neutralization by human sera","volume":"80","author":"JJ Carter","year":"2006","journal-title":"J Virol"},{"issue":"10","key":"ppat.1013086.ref019","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0140926","article-title":"Relationship between Humoral Immune Responses against HPV16, HPV18, HPV31 and HPV45 in 12-15 Year Old Girls Receiving Cervarix\u00ae or Gardasil\u00ae Vaccine","volume":"10","author":"A Godi","year":"2015","journal-title":"PLoS One"},{"issue":"6","key":"ppat.1013086.ref020","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1093\/infdis\/jiv519","article-title":"Cross-protection of the Bivalent Human Papillomavirus (HPV) Vaccine Against Variants of Genetically Related High-Risk HPV Infections","volume":"213","author":"A Harari","year":"2016","journal-title":"J Infect Dis"},{"issue":"7","key":"ppat.1013086.ref021","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1086\/597309","article-title":"The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in sexually active women aged 16-26 years","volume":"199","author":"CM Wheeler","year":"2009","journal-title":"J Infect Dis"},{"issue":"7","key":"ppat.1013086.ref022","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1086\/597307","article-title":"The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV-naive women aged 16-26 years","volume":"199","author":"DR Brown","year":"2009","journal-title":"J Infect Dis"},{"issue":"32","key":"ppat.1013086.ref023","doi-asserted-by":"crossref","first-page":"3922","DOI":"10.1016\/j.vaccine.2017.06.028","article-title":"Seropositivity to non-vaccine incorporated genotypes induced by the bivalent and quadrivalent HPV vaccines: A systematic review and meta-analysis","volume":"35","author":"SL Bissett","year":"2017","journal-title":"Vaccine"},{"key":"ppat.1013086.ref024","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41541-020-00236-w","article-title":"Structural characterization of a neutralizing mAb H16.001, a potent candidate for a common potency assay for various HPV16 VLPs","volume":"5","author":"W Huang","year":"2020","journal-title":"NPJ Vaccines"},{"issue":"7","key":"ppat.1013086.ref025","article-title":"Structural basis for the shared neutralization mechanism of three classes of human papillomavirus type 58 antibodies with disparate modes of binding","volume":"95","author":"M He","year":"2021","journal-title":"J Virol"},{"issue":"12","key":"ppat.1013086.ref026","doi-asserted-by":"crossref","first-page":"374","DOI":"10.3390\/v9120374","article-title":"High-Resolution Structure Analysis of Antibody V5 and U4 Conformational Epitopes on Human Papillomavirus 16","volume":"9","author":"J Guan","year":"2017","journal-title":"Viruses"},{"issue":"5","key":"ppat.1013086.ref027","article-title":"Crystal Structures of Two Immune Complexes Identify Determinants for Viral Infectivity and Type-Specific Neutralization of Human Papillomavirus","volume":"8","author":"Z Li","year":"2017","journal-title":"mBio"},{"issue":"2","key":"ppat.1013086.ref028","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1006\/viro.2001.1220","article-title":"Hybrid papillomavirus L1 molecules assemble into virus-like particles that reconstitute conformational epitopes and induce neutralizing antibodies to distinct HPV types","volume":"291","author":"ND Christensen","year":"2001","journal-title":"Virology"},{"issue":"3","key":"ppat.1013086.ref029","doi-asserted-by":"crossref","first-page":"734","DOI":"10.4161\/hv.27316","article-title":"Characterization of virus-like particles in GARDASIL\u00ae by cryo transmission electron microscopy","volume":"10","author":"Q Zhao","year":"2014","journal-title":"Hum Vaccin Immunother"},{"issue":"1","key":"ppat.1013086.ref030","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1080\/22221751.2019.1694396","article-title":"Neutralization sites of human papillomavirus-6 relate to virus attachment and entry phase in viral infection","volume":"8","author":"X Liu","year":"2019","journal-title":"Emerg Microbes Infect"},{"issue":"2","key":"ppat.1013086.ref031","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1128\/JVI.02898-14","article-title":"A cryo-electron microscopy study identifies the complete H16.V5 epitope and reveals global conformational changes initiated by binding of the neutralizing antibody fragment","volume":"89","author":"H Lee","year":"2015","journal-title":"J Virol"},{"key":"ppat.1013086.ref032","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.virol.2015.04.016","article-title":"Structural comparison of four different antibodies interacting with human papillomavirus 16 and mechanisms of neutralization","volume":"483","author":"J Guan","year":"2015","journal-title":"Virology"},{"issue":"1","key":"ppat.1013086.ref033","doi-asserted-by":"crossref","first-page":"5360","DOI":"10.1038\/s41467-018-07199-6","article-title":"Rational design of a triple-type human papillomavirus vaccine by compromising viral-type specificity","volume":"9","author":"Z Li","year":"2018","journal-title":"Nat Commun"},{"key":"ppat.1013086.ref034","doi-asserted-by":"crossref","first-page":"156241","DOI":"10.1155\/2015\/156241","article-title":"Structural and Computational Biology in the Design of Immunogenic Vaccine Antigens","volume":"2015","author":"L Liljeroos","year":"2015","journal-title":"J Immunol Res"},{"issue":"9","key":"ppat.1013086.ref035","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/s41573-022-00495-3","article-title":"Antibodies to combat viral infections: development strategies and progress","volume":"21","author":"G Pantaleo","year":"2022","journal-title":"Nat Rev Drug Discov"},{"key":"ppat.1013086.ref036","article-title":"Structures of human antibodies bound to SARS-CoV-2 spike reveal common epitopes and recurrent features of antibodies","author":"CO Barnes","year":"2020","journal-title":"bioRxiv"},{"key":"ppat.1013086.ref037","doi-asserted-by":"crossref","unstructured":"Robbiani DF, Gaebler C, Muecksch F, Lorenzi JCC, Wang Z, Cho A, et al. Convergent Antibody Responses to SARS-CoV-2 Infection in Convalescent Individuals. bioRxiv. 2020. https:\/\/doi.org\/10.1101\/2020.05.13.092619 32511384","DOI":"10.1101\/2020.05.13.092619"},{"issue":"7","key":"ppat.1013086.ref038","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.it.2014.04.005","article-title":"Studying the antibody repertoire after vaccination: practical applications","volume":"35","author":"JD Galson","year":"2014","journal-title":"Trends Immunol"},{"issue":"5","key":"ppat.1013086.ref039","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.cell.2015.04.028","article-title":"Viral receptor-binding site antibodies with diverse germline origins","volume":"161","author":"AG Schmidt","year":"2015","journal-title":"Cell"},{"issue":"1","key":"ppat.1013086.ref040","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/imr.12098","article-title":"Advances in antiviral vaccine development","volume":"255","author":"BS Graham","year":"2013","journal-title":"Immunol Rev"},{"key":"ppat.1013086.ref041","doi-asserted-by":"crossref","first-page":"19042","DOI":"10.1038\/srep19042","article-title":"A human monoclonal antibody against HPV16 recognizes an immunodominant and neutralizing epitope partially overlapping with that of H16.V5","volume":"6","author":"L Xia","year":"2016","journal-title":"Sci Rep"},{"key":"ppat.1013086.ref042","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ebiom.2016.06.042","article-title":"A Single Human Papillomavirus Vaccine Dose Improves B Cell Memory in Previously Infected Subjects","volume":"10","author":"EM Scherer","year":"2016","journal-title":"EBioMedicine"},{"issue":"4","key":"ppat.1013086.ref043","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1093\/infdis\/jix566","article-title":"Analysis of Memory B-Cell Responses Reveals Suboptimal Dosing Schedule of a Licensed Vaccine","volume":"217","author":"EM Scherer","year":"2018","journal-title":"J Infect Dis"},{"issue":"1","key":"ppat.1013086.ref044","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0042-6822(03)00179-X","article-title":"Mapping of human serum-reactive epitopes in virus-like particles of human papillomavirus types 16 and 11","volume":"311","author":"X Wang","year":"2003","journal-title":"Virology"},{"issue":"4","key":"ppat.1013086.ref045","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1002\/jmv.20492","article-title":"Mutations on the FG surface loop of human papillomavirus type 16 major capsid protein affect recognition by both type-specific neutralizing antibodies and cross-reactive antibodies","volume":"77","author":"GS Carpentier","year":"2005","journal-title":"J Med Virol"},{"key":"ppat.1013086.ref046","article-title":"A review of clinical trials of human papillomavirus prophylactic vaccines","author":"JT Schiller","year":"2012","journal-title":"Vaccine"},{"issue":"41","key":"ppat.1013086.ref047","doi-asserted-by":"crossref","first-page":"5357","DOI":"10.1016\/j.vaccine.2014.07.014","article-title":"Neutralizing and cross-neutralizing antibody titres induced by bivalent and quadrivalent human papillomavirus vaccines in the target population of organized vaccination programmes","volume":"32","author":"L Barzon","year":"2014","journal-title":"Vaccine"},{"issue":"3","key":"ppat.1013086.ref048","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.coi.2011.04.003","article-title":"Role of immune mechanisms in induction of HIV-1 broadly neutralizing antibodies","volume":"23","author":"L Verkoczy","year":"2011","journal-title":"Curr Opin Immunol"},{"issue":"5808","key":"ppat.1013086.ref049","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/290713a0","article-title":"Antigenic structure of influenza virus haemagglutinin defined by hybridoma antibodies","volume":"290","author":"W Gerhard","year":"1981","journal-title":"Nature"},{"key":"ppat.1013086.ref050","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.coviro.2019.02.004","article-title":"VH1-69 antiviral broadly neutralizing antibodies: genetics, structures, and relevance to rational vaccine design","volume":"34","author":"F Chen","year":"2019","journal-title":"Curr Opin Virol"},{"issue":"7467","key":"ppat.1013086.ref051","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/nature12442","article-title":"Cross-neutralization of four paramyxoviruses by a human monoclonal antibody","volume":"501","author":"D Corti","year":"2013","journal-title":"Nature"},{"key":"ppat.1013086.ref052","first-page":"250","article-title":"Immunologic Basis for Long HCDR3s in Broadly Neutralizing Antibodies Against HIV-1","volume":"5","author":"L Yu","year":"2014","journal-title":"Front Immunol"},{"issue":"6049","key":"ppat.1013086.ref053","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1126\/science.1207227","article-title":"Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 binding","volume":"333","author":"JF Scheid","year":"2011","journal-title":"Science"},{"issue":"4","key":"ppat.1013086.ref054","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2017.04.024","article-title":"Recurrent Potent Human Neutralizing Antibodies to Zika Virus in Brazil and Mexico","volume":"169","author":"DF Robbiani","year":"2017","journal-title":"Cell"},{"issue":"10","key":"ppat.1013086.ref055","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1038\/s41591-019-0602-4","article-title":"Polyclonal and convergent antibody response to Ebola virus vaccine rVSV-ZEBOV","volume":"25","author":"SA Ehrhardt","year":"2019","journal-title":"Nat Med"},{"issue":"4","key":"ppat.1013086.ref056","article-title":"Recurring and Adaptable Binding Motifs in Broadly Neutralizing Antibodies to Influenza Virus Are Encoded on the D3-9 Segment of the Ig Gene","volume":"24","author":"NC Wu","year":"2018","journal-title":"Cell Host Microbe"},{"key":"ppat.1013086.ref057","first-page":"445","article-title":"Generation of HPV pseudovirions using transfection and their use in neutralization assays","volume":"119","author":"CB Buck","year":"2005","journal-title":"Methods Mol Med"},{"issue":"10","key":"ppat.1013086.ref058","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004461","article-title":"Characteristics of memory B cells elicited by a highly efficacious HPV vaccine in subjects with no pre-existing immunity","volume":"10","author":"EM Scherer","year":"2014","journal-title":"PLoS Pathog"},{"issue":"3","key":"ppat.1013086.ref059","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/nprot.2009.3","article-title":"Rapid generation of fully human monoclonal antibodies specific to a vaccinating antigen","volume":"4","author":"K Smith","year":"2009","journal-title":"Nat Protoc"},{"issue":"1","key":"ppat.1013086.ref060","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0145-305X(02)00039-3","article-title":"IMGT unique numbering for immunoglobulin and T cell receptor variable domains and Ig superfamily V-like domains","volume":"27","author":"M-P Lefranc","year":"2003","journal-title":"Dev Comp Immunol"},{"issue":"2","key":"ppat.1013086.ref061","doi-asserted-by":"crossref","first-page":"356","DOI":"10.4014\/jmb.1511.11010","article-title":"High-Level Production of Human Papillomavirus (HPV) Type 16 L1 in Escherichia coli","volume":"26","author":"HB Bang","year":"2016","journal-title":"J Microbiol Biotechnol"},{"issue":"1","key":"ppat.1013086.ref062","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jsb.2005.07.007","article-title":"Automated electron microscope tomography using robust prediction of specimen movements","volume":"152","author":"DN Mastronarde","year":"2005","journal-title":"J Struct Biol"},{"issue":"4","key":"ppat.1013086.ref063","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nmeth.4193","article-title":"MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy","volume":"14","author":"SQ Zheng","year":"2017","journal-title":"Nat Methods"},{"issue":"3","key":"ppat.1013086.ref064","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nmeth.4169","article-title":"cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination","volume":"14","author":"A Punjani","year":"2017","journal-title":"Nat Methods"},{"issue":"4","key":"ppat.1013086.ref065","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1074\/jbc.M110.160184","article-title":"Structural basis of oligosaccharide receptor recognition by human papillomavirus","volume":"286","author":"J Dasgupta","year":"2011","journal-title":"J Biol Chem"},{"issue":"11","key":"ppat.1013086.ref066","article-title":"UCSF ChimeraX: Tools for structure building and analysis","volume":"32","author":"EC Meng","year":"2023","journal-title":"Protein Sci"},{"issue":"7873","key":"ppat.1013086.ref067","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"J Jumper","year":"2021","journal-title":"Nature"},{"key":"ppat.1013086.ref068","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1107\/S2059798318002425","article-title":"ISOLDE: a physically realistic environment for model building into low-resolution electron-density maps","volume":"74","author":"TI Croll","year":"2018","journal-title":"Acta Crystallogr D Struct Biol"},{"key":"ppat.1013086.ref069","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1107\/S0907444910007493","article-title":"Features and development of Coot","volume":"66","author":"P Emsley","year":"2010","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"ppat.1013086.ref070","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1107\/S2059798319011471","article-title":"Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix","volume":"75","author":"D Liebschner","year":"2019","journal-title":"Acta Crystallogr D Struct Biol"},{"issue":"1","key":"ppat.1013086.ref071","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/pro.3330","article-title":"MolProbity: More and better reference data for improved all-atom structure validation","volume":"27","author":"CJ Williams","year":"2018","journal-title":"Protein Sci"},{"issue":"10","key":"ppat.1013086.ref072","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/nmeth.3541","article-title":"EMRinger: side chain-directed model and map validation for 3D cryo-electron microscopy","volume":"12","author":"BA Barad","year":"2015","journal-title":"Nat Methods"},{"issue":"3","key":"ppat.1013086.ref073","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.jmb.2007.05.022","article-title":"Inference of macromolecular assemblies from crystalline state","volume":"372","author":"E Krissinel","year":"2007","journal-title":"J Mol Biol"}],"updated-by":[{"DOI":"10.1371\/journal.ppat.1013086","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000}}],"container-title":["PLOS Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1013086","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T17:59:18Z","timestamp":1761328758000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1013086"}},"subtitle":[],"editor":[{"given":"Zhen","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,10,21]]},"references-count":73,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.ppat.1013086","relation":{},"ISSN":["1553-7374"],"issn-type":[{"value":"1553-7374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,21]]}}}